48 results
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
26 Oct 23
Can-Fite to Harness Artificial Intelligence to Develop Novel Anti-Cancer Drugs
7:11am
and MegaPredict®. Collaborations Pharmaceuticals, Inc. performs research and development on innovative therapeutics for multiple rare and neglected diseases
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
28 Jun 21
Agreement with Vetbiolix for Development of Piclidenoson for Pets
7:08am
in the treatment of osteoarthritis in mammals.
About Vetbiolix
Vetbiolix develops innovative products for treatment and prevention of diseases affecting … exciting possibilities for pets. Vetbiolix has developed a unique approach focused on turning this potential into innovative prescription medicines
6-K
EX-99.1
vvrzy34t uu0zmo
16 Mar 21
Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma
7:08am
6-K
EX-99.1
fve57
28 Oct 20
Report of Foreign Private Issuer
4:31pm
424B5
bae1ld5xv4t 1rikr
8 Jul 20
Prospectus supplement for primary offering
10:42am
424B5
22e291l09z6q5w
12 Jun 20
Prospectus supplement for primary offering
8:30am
424B4
uqvbpo5skg
12 Feb 20
Prospectus supplement with pricing info
6:46am
F-1/A
a8t1v0p4y 2r
3 Feb 20
Registration statement (foreign) (amended)
5:31pm
F-1
bp84d2e5
24 Jan 20
Registration statement (foreign)
4:40pm
6-K
EX-99.1
l4y8vn3okmcfars eqgx
16 Jan 20
Can-Fite and Univo Pharmaceuticals Collaboration Result in Discovery and Applied Patent for Cannabinoid Formulations with Broad Therapeutic Effects
7:09am
F-1/A
EX-10.1
owfm81qoo
17 Oct 19
Registration statement (foreign) (amended)
5:29pm
6-K
EX-99.1
2d8cxhr2 dw4hvq
17 Oct 19
Report of Foreign Private Issuer
8:15am
6-K
EX-99.1
6zpv8s2efokvb6e
10 Sep 19
Can-Fite Enters into Strategic Agreement with Univo Pharmaceuticals to Develop Cannabinoid-Based Pharmaceuticals and Assays
6:08am
424B5
s0skl7 9ux6qj4qx
22 May 19
Prospectus supplement for primary offering
9:20am
424B5
2xb7h
4 Apr 19
Prospectus supplement for primary offering
9:19am